Bayer’s stroke drug wins fast-track review in US
The development comes as stroke remains one of the world’s biggest health threats
The development comes as stroke remains one of the world’s biggest health threats
Collaboration with Siddhi Diagnostics combines genomics and advanced imaging capabilities to strengthen precision diagnostics in high-growth suburban markets
Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
Growth driven by strong performance across Sugar Free, RiteBite Max Protein, Everyuth, Glucon-D and Nutralite portfolios
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
Growth was driven by expansion across key business segments, improving efficiencies, and sustained demand across institutional and retail channels
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
Subscribe To Our Newsletter & Stay Updated